A 59-year-old with NSTEMI started on DAPT and high-intensity statin asks about LDL-C target strategy. Which threshold best guides adding a PCSK9 inhib...

Question

A 59-year-old with NSTEMI started on DAPT and high-intensity statin asks about LDL-C target strategy. Which threshold best guides adding a PCSK9 inhibitor after ezetimibe?

Accepted Answer

LDL-C ≥70 mg/dL in very high-risk ASCVD after statin ± ezetimibe

Answer

LDL-C ≥100 mg/dL in all

Answer

LDL-C ≥55 mg/dL for all primary prevention

Answer

Non-HDL-C ≥160 mg/dL for all

Answer

Triglycerides ≥200 mg/dL for all

us-abim MCQ (SBA): ASCVD Lipid Management

A 59-year-old with NSTEMI started on DAPT and high-intensity statin asks about LDL-C target strategy. Which threshold best guides adding a PCSK9 inhibitor after ezetimibe?